Johnson Winter & Slattery is engaged by major businesses, investment funds and government agencies as legal counsel on important transactions and disputes throughout Australia and surrounding regions.
We are continually evolving and adapting our diversity and inclusion programs to better support our people, clients and communities.
Our news and media coverage including major transaction announcements, practitioner appointments and team expansions.
We support a number of community initiatives and not for profit organisations across Australia through pro bono legal work and charitable donations.
Our firm provides a diverse range of opportunities for talented, enthusiastic people to develop brilliant legal careers.
James is a corporate lawyer specialising in mergers and acquisitions, private equity transactions and equity capital markets.
He advises clients from a variety of industries including private equity sponsors. He is an expert in all aspects of domestic and cross-border M&A deals including public (takeovers and schemes of arrangements) and privately negotiated transactions and ECM deals including cross-border listings on the ASX.
James is qualified in both Australia and the US, and has for many years advised US clients doing business in Australia and Australian clients doing business in the US.
James has been consistently recognised by his peers (Best Lawyers) for each of M&A (since 2010), Private Equity (since 2010), Corporate & Venture Capital Law (since 2010) and by his clients (Chambers) as a leading individual, again for each of Corporate/M&A, Private Equity (2011-2021) and Capital Markets (2016-2021). In Chambers he is described as “easily the best private equity lawyer we have dealt with, especially on cross-border deals”and is regarded as a "solutions-based lawyer who is very hands-on during a deal" and is lauded for producing "high-quality work quickly and with strong client interaction.”
Acting in relation to its acquisition of Potential(x) (2021).
Acting in relation to its acquisition of SuperChoice Services (2021).
Acting in relation to its acquisition of Data Republic (2021).
Acting in relation to a series of acquisitions in Australia (2021).
Acting in relation to its acquisition of Honey Birdette (2021).
Acting in relation to its acquisition of NewBook (2021).
Acting in relation to its portfolio acquisitions by Micromine of Precision Mining (2021) and Alastri Holdings (2021).
Acting in relation to its portfolio acquisition by Incentive Solutions of OneAffiniti (2021).
Acting in relation to its portfolio acquisitions by Seisma of Smart Apps (2021), coIB (2021) and Braestone (2021).
Acting in relation to its portfolio acquisition by Lineage Logistics of Emergent Cold (2020).
Acting in relation to its acquisition of Commerce Vision (2021).
Acting in relation to its investment in the Bain Capital consortium for Virgin Australia (2020).
Acting in relation to its partial divestment of illion (2020).
Acting in relation to its acquisition of Melbourne IT Consulting (2020).
Acting in relation to its portfolio acquisition of Premier Technologies, a payments solution (2020).
Acting in relation to its acquisition of Kumo Holdings (2020).
Acting in relation to its proposed acquisition of FunLab (2020).
Advised on all corporate aspects of Potentia’s acquisition of 100% of PC-EFTPOS (2019).
Acting in relation to its acquisition of HotSchedules (formerly RedBook) (2019).
Acting in relation to its divestment of LCR Group to Qube (2019).
Acting in relation to its divestment of Marlin Brands (2019).
Advising on its acquisition of Micromine (2018).
Advising on its PIPE into Afterpay (ASX:APT) (2018).
Advising on its acquisition of Serraview Holdings (2018).
Advising on its acquisition of Pharmaceutical Packaging (2018).
Acting in relation to its divestment of AeroCare to Swissport (2018).
Acting in relation to its investment in Automic Group (2021).
Acting in relation to their investment in Stakeshop (2021).
Acting in relation to its investment in SafetyCulture (2021).
Acting in relation to its investment in Octopus Deploy (2021).
Acting in relation to its investment in Employment Hero (2021).
Acting in relation to its investment in Persuit (2021).
Acting on its portfolio divestment of Airtasker (2021).
Acting in relation to its investment in Linktree (2020).
Acting in relation to its investment in Buildkite (2020).
Acting on its portfolio investments in Health Engine (2020).
Advised on series B funding round of financing (2021).
Acting in relation to its investment in Canary (2020).
Advising on its seed investment in Dovetail (2020).
Acting in relation to its investment in Sunman energy (2020).
Advising on its Series B investment in Kasada (2020).
Advised on its Series B investment of Linktree (2020).
Advising on its Series A investment in Pegasus Management (2020).
Acting in relation to its investment in Pharmamark (2019).
Advising on its US-redomicile and seed financing (2019).
Acting in relation to on its Series B financing (2018).
Advising on the Initial Closing of its US$50 million Series C round of financing (2018).
Advising on on its Series A fundraising (2018).
Advising on its series A investment in Humanforce, a workplace management solution (2018).
Advising on their series C investment in Deputy Group (2018).
Advising on its investment by Peakspan Capital (2018).
Advising on its seed investment in Popgun Labs (2018).
Advising on their investment in EBR Systems (2017).
Acting for Laybuy Limited on its pre-IPO and IPO and ASX-listing (2020).
Acting for Imricor Medical Systems on its IPO and ASX-listing (2019).
Acting on its IPO and ASX-listing (2017).
Acting on its proposed IPO and ASX-listing (2017).
Acting for AirXpanders on its IPO and ASX-listing (2015).
Named lawyer of the year in venture capital law
Ranked as a leading lawyer in corporate/M&A and private equity
Ranked as a leading lawyer in capital markets: equity
James Rozsa is "very strong and commercial across key issues, and is very responsive and able to deal with situations that come up last-minute," according to one client. He frequently acts for clients on IPOs and ASX listings.
Listed as a leading lawyer in mergers and acquisitions, corporate/governance practice, corporate, equity capital markets, private equity and venture capital law
One client describes James as "knowledgeable and responsive", adding that "he also understands US law and can help a US company publicly trade in Australia"
James Rozsa is a "commercial problem solver who holds 'trusted adviser' status"
James Rozsa has "a great understanding of private equity deals and is always keen to provide innovative solutions”
James Rozsa is praised for being "very commercial, well-connected and solutions-oriented”
James Rozsa is ... particularly valued by clients as an adviser with "the rare quality of assessing risk rather than just identifying it and focusing on the stuff that poses genuine problems"
James Rozsa is highlighted for his "legal expertise and great professional advice," and also for his "great communication skills and management of investor expectations and concerns"
James Rozsa is described as a "solutions-based lawyer who is very hands-on during a deal," and is also lauded for producing "high-quality work quickly and with strong client interaction"
James Rozsa is praised by clients for his "tireless work on documentation" and for proving "good in both service and content"
On 16 October 2017, the Broadcasting Legislation Amendment (Broadcasting Reform) Bill 2017 (Cth) was passed by Australia’s House of Representatives and granted Royal assent. Following the Royal...
There are a number of associated issues and uncertainties regarding a new exemption certificate for business acquisitions by foreign investors (Business EC).
In February 2017, the Australian Government released a consultation paper titled ‘Increasing Transparency of the Beneficial Ownership of Companies’ (Consultation Paper) to explore the potential to...